Cardiac transplantation for ischemic heart disease

Robroy H. MacIver, Edwin C. McGee*, Patrick M McCarthy

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

According to recent data by the American Heart Association, Coronary Artery Disease (CAD) has a prevalence of 6.9% in the US population [1]. In 2002, 494,382 people died in the USA from the effects of CAD with a cost that reached 142.1 billion dollars in 2005 [1]. It is well established that patients with evidence of myocardial viability and target vessels for revascularization live longer with surgical revascularization as opposed to medical management especially if they have severe left ventricular dysfunction [2]. However, patients who reach end-stage ischemic-cardiomyopathy without evidence of viability do not benefit from revascularization [2]. This chapter discusses transplantation as treatment for these patients with end-stage ischemic cardiomyopathy.

Original languageEnglish (US)
Title of host publicationCoronary Artery Disease
Subtitle of host publicationNew Approaches without Traditional Revascularization
PublisherSpringer-Verlag London Ltd
Pages109-123
Number of pages15
Volume9781846287121
ISBN (Electronic)9781846287121
ISBN (Print)1846284600, 9781846284601
DOIs
StatePublished - Apr 1 2012

Fingerprint

Heart Transplantation
Myocardial Ischemia
Cardiomyopathies
Coronary Artery Disease
Left Ventricular Dysfunction
Transplantation
Costs and Cost Analysis
Population
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

MacIver, R. H., McGee, E. C., & McCarthy, P. M. (2012). Cardiac transplantation for ischemic heart disease. In Coronary Artery Disease: New Approaches without Traditional Revascularization (Vol. 9781846287121, pp. 109-123). Springer-Verlag London Ltd. https://doi.org/10.1007/978-1-84628-712-1_10
MacIver, Robroy H. ; McGee, Edwin C. ; McCarthy, Patrick M. / Cardiac transplantation for ischemic heart disease. Coronary Artery Disease: New Approaches without Traditional Revascularization. Vol. 9781846287121 Springer-Verlag London Ltd, 2012. pp. 109-123
@inbook{10600b6c2b8e4936a94f6a6249d4db01,
title = "Cardiac transplantation for ischemic heart disease",
abstract = "According to recent data by the American Heart Association, Coronary Artery Disease (CAD) has a prevalence of 6.9{\%} in the US population [1]. In 2002, 494,382 people died in the USA from the effects of CAD with a cost that reached 142.1 billion dollars in 2005 [1]. It is well established that patients with evidence of myocardial viability and target vessels for revascularization live longer with surgical revascularization as opposed to medical management especially if they have severe left ventricular dysfunction [2]. However, patients who reach end-stage ischemic-cardiomyopathy without evidence of viability do not benefit from revascularization [2]. This chapter discusses transplantation as treatment for these patients with end-stage ischemic cardiomyopathy.",
author = "MacIver, {Robroy H.} and McGee, {Edwin C.} and McCarthy, {Patrick M}",
year = "2012",
month = "4",
day = "1",
doi = "10.1007/978-1-84628-712-1_10",
language = "English (US)",
isbn = "1846284600",
volume = "9781846287121",
pages = "109--123",
booktitle = "Coronary Artery Disease",
publisher = "Springer-Verlag London Ltd",

}

MacIver, RH, McGee, EC & McCarthy, PM 2012, Cardiac transplantation for ischemic heart disease. in Coronary Artery Disease: New Approaches without Traditional Revascularization. vol. 9781846287121, Springer-Verlag London Ltd, pp. 109-123. https://doi.org/10.1007/978-1-84628-712-1_10

Cardiac transplantation for ischemic heart disease. / MacIver, Robroy H.; McGee, Edwin C.; McCarthy, Patrick M.

Coronary Artery Disease: New Approaches without Traditional Revascularization. Vol. 9781846287121 Springer-Verlag London Ltd, 2012. p. 109-123.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Cardiac transplantation for ischemic heart disease

AU - MacIver, Robroy H.

AU - McGee, Edwin C.

AU - McCarthy, Patrick M

PY - 2012/4/1

Y1 - 2012/4/1

N2 - According to recent data by the American Heart Association, Coronary Artery Disease (CAD) has a prevalence of 6.9% in the US population [1]. In 2002, 494,382 people died in the USA from the effects of CAD with a cost that reached 142.1 billion dollars in 2005 [1]. It is well established that patients with evidence of myocardial viability and target vessels for revascularization live longer with surgical revascularization as opposed to medical management especially if they have severe left ventricular dysfunction [2]. However, patients who reach end-stage ischemic-cardiomyopathy without evidence of viability do not benefit from revascularization [2]. This chapter discusses transplantation as treatment for these patients with end-stage ischemic cardiomyopathy.

AB - According to recent data by the American Heart Association, Coronary Artery Disease (CAD) has a prevalence of 6.9% in the US population [1]. In 2002, 494,382 people died in the USA from the effects of CAD with a cost that reached 142.1 billion dollars in 2005 [1]. It is well established that patients with evidence of myocardial viability and target vessels for revascularization live longer with surgical revascularization as opposed to medical management especially if they have severe left ventricular dysfunction [2]. However, patients who reach end-stage ischemic-cardiomyopathy without evidence of viability do not benefit from revascularization [2]. This chapter discusses transplantation as treatment for these patients with end-stage ischemic cardiomyopathy.

UR - http://www.scopus.com/inward/record.url?scp=84930023496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930023496&partnerID=8YFLogxK

U2 - 10.1007/978-1-84628-712-1_10

DO - 10.1007/978-1-84628-712-1_10

M3 - Chapter

SN - 1846284600

SN - 9781846284601

VL - 9781846287121

SP - 109

EP - 123

BT - Coronary Artery Disease

PB - Springer-Verlag London Ltd

ER -

MacIver RH, McGee EC, McCarthy PM. Cardiac transplantation for ischemic heart disease. In Coronary Artery Disease: New Approaches without Traditional Revascularization. Vol. 9781846287121. Springer-Verlag London Ltd. 2012. p. 109-123 https://doi.org/10.1007/978-1-84628-712-1_10